Alison D. Findlay
20 Rodborough Road
Frenchs Forest, NSW 2086, Australia
Frenchs Forest, NSW 2086, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A randomized, double-blind, placebo-controlled phase 1 trial of the topical pan-lysyl oxidase inhibitor PXS-6302 in mature scars.
Journal: Science translational medicine
Published: September 10, 2025
A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis.
Journal: Haematologica
Published: December 24, 2024
Stabilization of the open conformation οf insulin-regulated aminopeptidase by a novel substrate-selective small-molecule inhibitor.
Journal: Protein science : a publication of the Protein Society
Published: June 06, 2024
Author Correction: Topical application of an irreversible small molecule inhibitor of lysyl oxidases ameliorates skin scarring and fibrosis.
Journal: Nature communications
Published: January 10, 2023
Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease.
Journal: Bioorganic & medicinal chemistry letters
Published: June 03, 2022
Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis.
Journal: International journal of molecular sciences
Published: March 25, 2022
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.
Journal: Nature cancer
Published: September 28, 2021
An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies.
Journal: Clinical and translational medicine
Published: July 18, 2021
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
Journal: Journal of medicinal chemistry
Published: October 04, 2019
Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice.
Journal: International journal of hematology
Published: April 25, 2019
Last Updated: 09/26/2026